Skip to content
GLP1-US
Prices checked Wegovy pill $149 Wegovy pen $349 Zepbound $299–449 Foundayo from $149 Ozempic $349 Medicare Bridge $50 Compounded sema $175 All prices →

FDA label revised 08/2026 · prices checked Oct 2026

What Is Zepbound? Lilly's Weekly Tirzepatide Shot, KwikPen and Vials Explained

Zepbound is Eli Lilly's once-weekly tirzepatide injection, FDA-approved for chronic weight management in adults since Nov 8, 2023 and for moderate to severe sleep apnea with obesity since Dec 20, 2024.

  • Tirzepatide, once a week
  • FDA-approved: weight and OSA
  • KwikPen, vial or single-dose pen
  • Prescription only

We may earn a commission when you click links to providers, and partner relationships can affect which providers we feature and their order. Advertiser Disclosure

By GLP1-US Editorial TeamUpdated
★ Editor's Choice
Chia Health logo

Chia Health

Our #1 pick for GLP-1 weight loss online

  • One monthly price: clinician, medication and free shipping included
  • Semaglutide or tirzepatide, as a weekly injection or a daily tablet
  • No insurance needed; HSA/FSA and Klarna accepted

Compounded medications, not FDA-approved. Prices checked Nov 17, 2026. Advertiser Disclosure

$212.89 first month, then $349/mo

6-month plan: $249/mo, paid upfront ($1,396.89 for the first 6 months). Microdose: $109.19 first month, then $179/mo.

Get Started Read our Chia Health review

01 The basics

What Is Zepbound? The Short Version

Zepbound is the brand name Eli Lilly uses for tirzepatide when it is prescribed for weight. It is a once-weekly injection under the skin, used together with a reduced-calorie diet and more physical activity (label section 1). It needs a prescription, and every dose is measured in milligrams from a labeled pen or vial.

Approved for weight
Nov 8, 2023
FDA, adults
Approved for sleep apnea
Dec 20, 2024
moderate to severe OSA with obesity
Dose range
2.5 to 15 mg
once weekly, 6 strengths
First approval of tirzepatide
2022
as Mounjaro, for type 2 diabetes

The label carries a boxed warning: tirzepatide caused thyroid C-cell tumors in rats, and Zepbound is not for anyone with a personal or family history of medullary thyroid carcinoma or with MEN 2 (section 4). Whether it causes these tumors in people is unknown.

02 The molecule

Zepbound Tirzepatide: How It Works and How It Differs From Mounjaro

Tirzepatide acts on two gut-hormone receptors at once, GIP and GLP-1 (label section 12.1). GLP-1 helps regulate appetite and how much you eat, and the label says the GIP part may add to that effect; both receptors sit in brain areas that control appetite. A fatty-acid chain lets the drug bind to albumin in the blood, which is why one shot lasts a week.

FeatureZepboundMounjaro
Active drugtirzepatidetirzepatide
MakerEli LillyEli Lilly
FDA-approved forChronic weight management; OSA with obesityType 2 diabetes
Doses2.5 to 15 mg weekly2.5 to 15 mg weekly
Forms on the labelKwikPen, multi-dose vial, single-dose vial, single-dose penSame four forms
Medicare GLP-1 Bridge$50 a month (KwikPen only)Regular Part D, for diabetes

Same molecule, different label, and the label says not to combine Zepbound with any other tirzepatide product or any GLP-1 drug (section 1). Is it a GLP-1? Partly: it is a dual GIP and GLP-1 agonist, explained in is Zepbound a GLP-1. Full side-by-side: Mounjaro and Zepbound guide. The molecule itself: tirzepatide.

03 Approved uses

What Zepbound Is FDA-Approved For (and What It Is Not)

Weight reduction and long-term maintenance

For adults with obesity, or adults with overweight plus at least one weight-related condition such as high blood pressure or high cholesterol (section 1). The main weight trial, SURMOUNT-1, enrolled adults with a BMI of 30 or higher, or 27 to 30 with a related condition. Maintenance doses: 5, 10 or 15 mg. Trial numbers by dose and week: Zepbound results.

Moderate to severe obstructive sleep apnea (OSA) in adults with obesity

Added Dec 20, 2024; the FDA called it the first medication approved for OSA. Approved on two 52-week trials, one in people not using a CPAP machine and one in people who were (section 14.2). Maintenance doses: 10 or 15 mg. Who qualifies and what the trials measured: Zepbound for sleep apnea.

Not FDA-approved uses

  • Children and teens (safety not established, section 8.4)
  • Type 2 diabetes alone: that is Mounjaro
  • Psoriasis: studied with Taltz, not approved
  • Together with another GLP-1 or tirzepatide drug

The psoriasis data come from Lilly's TOGETHER-PsO trial; summary in our Oct 9 news note. PCOS is not on the label either (GLP-1 for PCOS); for teens, see which GLP-1s are approved under 18. Every GLP-1 use by drug: GLP-1 uses.

04 Devices

Zepbound KwikPen vs Vials vs Single-Dose Pen

The milligram dose is the same whichever form you get. What changes is the device, how many doses it holds and what else you need. Your prescriber chooses the form, and the label requires training on that exact device before the first shot (section 2.4).

Zepbound KwikPen

Newest form, Feb 23, 2026

  • Holds 4 weekly doses of one strength, 2.4 mL in total, 0.6 mL per dose (section 3)
  • You attach a new pen needle every week and prime before each dose
  • Throw it away after 4 doses or 30 days after first use, even if liquid is left (16.2)
  • Single-patient use: never share, even with a new needle (5.10)
  • Not recommended for self-injection by people who are visually impaired (2.4)
  • LillyDirect self-pay: $299 / $399 / $449 by dose; Medicare GLP-1 Bridge: $50 a month

Zepbound vials

Single-dose or multi-dose

  • Single-dose vial: 1 dose of 0.5 mL, sold as 1 or 4 vials per carton (16.1)
  • Multi-dose vial: 4 doses of 0.6 mL, 2.4 mL in total
  • New 1 mL syringe and needle for every shot (2.4)
  • Multi-dose vial: throw away after 4 doses or 30 days after first use
  • LillyDirect self-pay: same price as the KwikPen (4 single-dose vials = 1 month)
  • Not covered by the Medicare GLP-1 Bridge

Zepbound single-dose pen

Autoinjector

  • 1 dose of 0.5 mL with a hidden, built-in needle; a carton holds 4 pens (16.1)
  • Nothing to attach, no priming; you press a button and it injects
  • Can stay out of the fridge up to 86°F for 21 days in total (16.2)
  • Outside the LillyDirect $299 self-pay offer; $499 a month under Lilly's no-coverage savings card
  • Common route when insurance covers Zepbound

Vials and the KwikPen have cost the same on LillyDirect since Feb 23, 2026. Price detail by dose and the 45-day refill rule: Zepbound cost.

05 Strengths

Zepbound Pen Strengths: How Each Form Is Supplied

Zepbound strengths by presentation, FDA label sections 3 and 16.1, revised 08/2026
Weekly doseSingle-dose pen or vialKwikPen or multi-dose vial (4 doses)
2.5 mg2.5 mg / 0.5 mL10 mg / 2.4 mL (4.17 mg/mL)
5 mg5 mg / 0.5 mL20 mg / 2.4 mL (8.33 mg/mL)
7.5 mg7.5 mg / 0.5 mL30 mg / 2.4 mL (12.5 mg/mL)
10 mg10 mg / 0.5 mL40 mg / 2.4 mL (16.7 mg/mL)
12.5 mg12.5 mg / 0.5 mL50 mg / 2.4 mL (20.8 mg/mL)
15 mg15 mg / 0.5 mL60 mg / 2.4 mL (25 mg/mL)

The "60 mg" printed on a 15 mg KwikPen is the total in the pen, not one dose: it delivers four 15 mg shots. Every Zepbound product is a clear, colorless to slightly yellow liquid; do not use it if you see particles or a color change (section 2.4). Unopened pens and vials go in the fridge at 36°F to 46°F and must never be frozen (16.2).

06 KwikPen

Using a Zepbound KwikPen: 5 Things That Differ From a Single-Dose Pen

  1. 01

    Attach a new pen needle each week. The KwikPen has no built-in needle; keep the outer needle shield to remove the needle afterward.

  2. 02

    Prime before every dose. Turn the knob to the prime position, point the needle up and push until it stops, then set your dose.

  3. 03

    Hold for a slow count of 5 after the knob is pushed all the way in.

  4. 04

    Remove the needle right away into a sharps container. Do not store the pen with a needle on.

  5. 05

    Track the count. After the 4th dose, or 30 days after first use, the pen goes in the trash even if liquid remains.

These are highlights of Lilly's Instructions for Use, not a replacement. Full injection steps for all three devices, plus injection sites and missed doses: Zepbound doses and how to inject.

07 Doses

Zepbound Doses at a Glance

  1. 2.5 mg weeks 1 to 4, start only
  2. 5 mg maintenance
  3. 7.5 mg step
  4. 10 mg maintenance
  5. 12.5 mg step
  6. 15 mg maximum

Everyone starts at 2.5 mg once a week for 4 weeks, then moves to 5 mg (section 2.1). Your prescriber can raise the dose by 2.5 mg after at least 4 weeks on the current one, up to 15 mg. For weight, 5, 10 and 15 mg are maintenance doses; for sleep apnea, 10 or 15 mg. Full schedule, chart and missed-dose rules: Zepbound doses.

08 In numbers

Results, Side Effects and Cost in Three Numbers

Average weight loss, 72 weeks, 15 mg
20.9%
vs 3.1% on placebo, SURMOUNT-1 (label Table 2)
Zepbound results by dose
Nausea on 5 to 15 mg
25% to 29%
vs 8% on placebo (label Table 1)
Zepbound side effects
Self-pay per month
$299 to $449
LillyDirect, refill within 45 days; $25 with covered insurance
Zepbound cost

Results shown are averages from a 72-week trial with diet and activity; individual results vary. Other label warnings include pancreatitis, gallbladder disease, kidney injury from dehydration and severe stomach reactions, and anyone having surgery under anesthesia should tell the care team they take it.

PlushCare works with 65+ insurers and sends FDA-approved prescriptions to your own pharmacy: $19.99 a month membership, $129 a visit without insurance.

Ask a PlushCare doctor if Zepbound fits you

09 Pill vs shot

Is There a Zepbound Pill?

Pill vs shot

Can I take Zepbound as a pill?

No. As of Oct 2026, Zepbound and every other tirzepatide product are injections only. Lilly's once-daily weight-loss pill is a different drug, Foundayo (orforglipron), approved Apr 1, 2026, with LillyDirect self-pay from $149 a month. Lilly's oral option: Foundayo. Why "tirzepatide pills" sold online are not Zepbound: Zepbound pill explained.

Compounded tirzepatide sold online is not FDA-approved and is not Zepbound. More: compounded tirzepatide explained; for semaglutide, compounded semaglutide.

10 Getting it

How to Get Zepbound

Zepbound needs a prescription from a licensed clinician, in person or by telehealth. The route depends mostly on your coverage.

No insurance coverage: self-pay

LillyDirect sells the KwikPen or vials at $299 (2.5 mg), $399 (5 mg) and $449 (7.5 to 15 mg) a month with an on-time refill. Telehealth programs like Ro send the prescription and add a membership fee ($39 first month, then $74 to $149 a month at Ro). Brand-only telehealth options: Zepbound online.

Commercial insurance

If your plan covers Zepbound, Lilly's 2026 savings card can bring a fill to $25 (max $1,300 a year, expires Dec 31, 2026). Many plans require prior authorization. Plan rules and appeals: Zepbound insurance.

Medicare Part D

The Medicare GLP-1 Bridge charges $50 a month for the Zepbound KwikPen, not vials, from Jul 1, 2026 to Dec 31, 2027 if you meet the BMI rules. Amazon Pharmacy delivers the KwikPen at that copay. Rules: Medicare GLP-1 Bridge.

How Zepbound compares with semaglutide: Zepbound vs Wegovy. Safety questions about the whole class: is semaglutide safe.

11 FAQ

Zepbound FAQ

What is Zepbound used for?
Zepbound is FDA-approved for two uses in adults, both alongside diet and exercise. First, to lose excess weight and keep it off in people with obesity, or overweight plus a weight-related condition (approved Nov 8, 2023). Second, to treat moderate to severe obstructive sleep apnea in people with obesity (approved Dec 20, 2024). It is not approved for type 2 diabetes alone, for children, or for psoriasis.
Is Zepbound the same as tirzepatide?
Zepbound is a brand of tirzepatide made by Eli Lilly. The same molecule is sold as Mounjaro for type 2 diabetes, at the same six strengths from 2.5 to 15 mg. Tirzepatide activates both the GIP and GLP-1 receptors. Compounded tirzepatide from a pharmacy or website is not Zepbound and is not FDA-approved; its dose and purity are not checked by the FDA.
What is the Zepbound KwikPen?
The KwikPen is a multi-dose Zepbound pen Lilly launched on Feb 23, 2026. Each pen holds 4 weekly doses of one strength, 2.4 mL in total. You attach a new needle and prime the pen before each shot, then throw it away after 4 doses or 30 days. On LillyDirect it costs the same as vials: $299, $399 or $449 a month by dose.
Is the Zepbound pen the same as the KwikPen?
No. The original Zepbound pen is a single-dose autoinjector: one 0.5 mL dose, a built-in hidden needle, and 4 pens per carton for a month. The KwikPen holds 4 doses of 0.6 mL and needs a new pen needle each week. The single-dose pen is outside the $299 LillyDirect offer and costs $499 a month under Lilly's no-coverage savings card.
How long does a Zepbound KwikPen last?
One KwikPen covers one month: 4 weekly doses. After first use it is good for 30 days, in the fridge or at room temperature up to 86°F, and must be thrown away after the 4th dose or day 30, whichever comes first, even if liquid is left. Unopened, it keeps until the expiration date in the fridge, or 30 days at room temperature.
Is Zepbound a GLP-1?
Partly. Zepbound is a dual agonist: it activates the GLP-1 receptor, like Wegovy and Ozempic, and the GIP receptor, which semaglutide does not. That is why the label calls it a GIP receptor and GLP-1 receptor agonist. In SURMOUNT-1, people on the 15 mg dose lost an average of 20.9% of body weight at 72 weeks, against 3.1% on placebo.
Does Medicare cover Zepbound?
For weight loss, yes through the Medicare GLP-1 Bridge: eligible Part D members pay $50 a month for the Zepbound KwikPen (not vials) from Jul 1, 2026 to Dec 31, 2027. You need a BMI of 35 or higher; or 30 or higher with conditions such as uncontrolled high blood pressure; or 27 or higher with prediabetes or a prior heart attack or stroke.

Label facts from the Zepbound Prescribing Information revised 08/2026; prices checked Oct 2026. General information, not medical advice; your prescriber decides whether Zepbound is right for you.

Medical Disclaimer

This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed physician or qualified health provider with any questions about a medical condition or medication. Never disregard professional medical advice or delay seeking it because of something you have read on this website.

Checked against primary sources such as FDA labels, CMS and provider pages
Updated
How we check facts →